Sophie Vo

I am an Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

My keen interest in all things life sciences and healthcare stems from my scientific background, as I studied pharmacology at university, as well as my intrigue in the way groundbreaking research and innovation impacts health outcomes and quality of life.

My practice consists of both contentious and non-contentious IP and regulatory matters across the life sciences product-to-market cycle.

In relation to IP enforcement, my experience includes patent litigation in the English High Court and Federal Court of Australia. These cases involved mRNA vaccines, electrochemical treatments, biopharmaceuticals and medical devices. My work in this space is complemented by my STEM background.

My experience also includes advising on a variety of commercial and corporate matters that are IP-rich and involve complex regulatory issues, including research collaborations, licensing arrangements, and manufacturing and supply services. This work tends to consist of advising on the creation and ownership of IP as well as the rights to use it. It also tends to require knowledge of regulatory and product compliance issues. I have worked on transactions that concern medicines, medical devices, software, agrochemicals, healthcare services provision, etc.

I also advise on regulatory issues generally, such as bringing medicines and medical devices to market, advertising and promotions clearances, and health services delivery.

I am an editor of Bird & Bird Patent Hub blog, and a co-author of the 'Guide to EU and UK Pharmaceutical Regulatory Law' (Kluwer Law International), along with my European/UK colleagues.

• BioNTech and Pfizer v CureVac [2024] EWHC 2538 (Pat)
• InterDigital Technology Corporation v Guangdong Oppo Mobile Telecommunications & others (HP-2021-000047)
• Vector Corrosion Technologies Limited v E-Chem Technologies Ltd [2022] FCA 188